California Best Selling Cannabis Strains in 2025

California’s cannabis market continues to set national trends, and 2025 offered a clear picture of what consumers kept coming back for. With thousands of cultivars competing across dispensary shelves, only a select few consistently rose to the top. Once again, Blue Dream stood above the rest, extending its reign among California best selling cannabis strains for a third straight year.

Drawing from sales data provided by Headset and the California Department of Cannabis Control, this report examines which cultivars dominated flower, pre-rolls, vapor pens, and concentrates during the first eleven months of 2025.

Key Takeaways

• Blue Dream led sales across flower, pre-roll, and vape categories
• California flower sales reached $1.23 billion through November
• Sativa-forward strains continued to drive pre-roll demand
• D Cure remained the top-selling concentrate cultivar
• New entrants like King Louis signaled evolving consumer preferences

Blue Dream Leads California Best Selling Cannabis Strains for a Third Year

For the third consecutive year, Blue Dream finished as California’s top-selling cultivar. This sativa-dominant hybrid, bred from Blueberry and Haze, is widely recognized for its sweet, earthy aroma and balanced effects that appeal to both medical and adult-use consumers.

In 2025, Blue Dream generated $21.7 million in flower sales, comfortably outpacing competitors such as Cereal Milk, Gelato, and OG #18. Even with that success, Blue Dream accounted for just 1.8% of total flower sales, a reminder of how fragmented California’s market remains.

Many consumers continue to favor Blue Dream for its association with managing stress, anxiety, chronic pain, and mood-related symptoms, while others value its clear-headed, functional effects.

Flower Sales Reflect Stability With One Notable Shift

The flower category remained anchored by familiar favorites throughout 2025. Cereal Milk, Gelato, and OG #18 all posted strong numbers, reinforcing their long-standing popularity.

The most significant change came from King Louis, which entered the flower top 10 for the first time with $10.6 million in sales. At the same time, Gush Mintz slipped out of the rankings, illustrating how quickly momentum can shift in a crowded marketplace.

Collectively, the top 10 flower strains still represented only a small portion of California’s $1.23 billion flower market, even among the most successful California best selling cannabis strains.

Pre-Rolls Continue to Favor Uplifting Cultivars

Pre-rolls remained one of the state’s most competitive product categories, and Blue Dream again led the pack. Consumers spent $26.6 million on Blue Dream pre-rolls in 2025, far surpassing runner-up Strawberry Cough.

Two cultivars made their first appearance in the pre-roll top 10. Cereal Milk and King Louis both posted strong debuts, while Watermelon and Maui Wowie fell off the list.

Sales trends showed a consistent preference for sativa-only pre-rolls, which outperformed indica-only and hybrid options. Blue Dream alone captured roughly 3.8% of all pre-roll sales statewide, cementing its role among California best-selling cannabis strains.

Vapor Pens Deliver Blue Dream’s Largest Sales Totals

Vapor pens produced Blue Dream’s highest revenue figures in 2025. Consumers spent $44.4 million on Blue Dream vape products, placing it well ahead of strains like Pineapple Express, Watermelon, and Strawberry Cough.

While the top 10 vapor pen cultivars remained unchanged from 2024, Watermelon showed the most growth, adding nearly $4.7 million in additional sales year over year.

Overall, Blue Dream accounted for about 3.5% of California’s total vape sales, demonstrating its consistent appeal across multiple consumption formats.

Concentrates Follow a Different Sales Pattern

Concentrates told a different story in 2025. D Cure led the category with $7.4 million in sales, more than doubling the revenue of its closest competitors.

This Chemdog x Grape Stomper cross is known for its uplifting, talkative effects and is commonly associated with relief from inflammation, pain, and arthritis. After topping concentrate sales in 2024, D Cure expanded its lead even further in 2025.

Newcomers Sherbert and Pineapple entered the concentrate top 10, replacing Gelato and Donny Burger. D Cure ultimately captured approximately 2.4% of California’s concentrate market.

Final Thoughts

The 2025 data reinforces a consistent pattern in California cannabis sales. Familiar strains with broad appeal continue to outperform short-lived trends, and few cultivars embody that better than Blue Dream. Its dominance across flower, pre-rolls, and vapor pens reflects deep consumer trust built over time.

At the same time, emerging performers like King Louis and the continued strength of D Cure show that innovation still has room to thrive. Together, these results offer a clear snapshot of what resonated most with buyers among California best selling cannabis strains during the past year.